EKTAF (Elekta AB) OCF Yield %: 13.85 (As of Jul. 02, 2026) — 138% Above Median


EKTAF Elekta AB EKTAF
77 GF Score
Price $5.04
GF Value $6.95
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Elekta AB OCF Yield %?

Elekta AB EKTAF 77 OCF Yield % is 13.85 as of Jul. 02, 2026, which is 138% above its 10-year median of 5.83. GuruFocus rates EKTAF with a GF Score™ of 77/100 and a GF Value™ of $6.95 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Elekta AB ranks better than 91.46% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Elekta AB's Trailing 12-Month Cash Flow from Operations is $266 Mil, and Market Cap is $1,937 Mil. Therefore, Elekta AB's OCF Yield % for today is 13.85%.

The historical rank and industry rank for Elekta AB's OCF Yield % or its related term are showing as below:

EKTAF' s OCF Yield % Range Over the Past 10 Years
Min: 2.37   Med: 5.83   Max: 19.78
Current: 13.85


During the past 13 years, the highest OCF Yield % of Elekta AB was 19.78%. The lowest was 2.37%. And the median was 5.83%.

EKTAF's OCF Yield % is ranked better than
91.46% of 855 companies
in the Medical Devices & Instruments industry
Industry Median: 1.71 vs EKTAF: 13.85

Elekta AB's OCF Margin % for the quarter that ended in Apr. 2026 was %.


Elekta AB OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Elekta AB OCF Yield % Related Terms


Elekta AB OCF Yield % Historical Data

* Premium members only.

The historical data trend for Elekta AB's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elekta AB OCF Yield % Chart

Elekta AB Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.50 5.96 7.88 14.07 11.22

Elekta AB Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.61 -1.88 14.01 9.47 25.14

EKTAF vs ABT, SYK, MDT: OCF Yield % Comparison

For the Medical Devices subindustry, Elekta AB's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elekta AB OCF Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elekta AB's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Elekta AB's OCF Yield % falls into.


EKTAF
77GF Score
Elekta AB EKTAF
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elekta AB OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Elekta AB's OCF Yield % for the fiscal year that ended in Apr. 2026 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=265.835 / 2368.9146
=11.22%

Elekta AB's annualized OCF Yield % for the quarter that ended in Apr. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=148.885 * 4 / 2368.9146
=25.14%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of 13.85 mean?
Elekta AB (EKTAF) has a OCF Yield % of 13.85 as of Jul. 02, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Elekta AB and its competitors. This is 138% above median its historical median of 5.83. Over the past decade, Elekta AB's OCF Yield % has ranged from 2.37 to 19.78. According to the industry distribution chart, Elekta AB ranks #73 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 8.5%.
Is Elekta AB's OCF Yield % too high?
Elekta AB's current OCF Yield % of 13.85 is 138% above median its 10-year median of 5.83. Over the past 10 years, this metric has ranged from a low of 2.37 to a high of 19.78. The Medical Devices & Instruments industry median OCF Yield % is 1.71. Elekta AB's value of 13.85 is 709.9% above this industry median. Based on the distribution chart, Elekta AB ranks #73 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Elekta AB has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elekta AB's OCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Elekta AB ranks #73 out of 855 companies for OCF Yield %. This places Elekta AB in the top 9% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.71. Elekta AB's value of 13.85 is 709.9% above this benchmark. Historically, Elekta AB's own OCF Yield % has ranged from 2.37 to 19.78 over the past decade. While the company's 10-year median is 5.83 vs. the industry median of 1.71, Elekta AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.71, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elekta AB's current OCF Yield % of 13.85 is 709.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Elekta AB and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elekta AB's current OCF Yield % is 13.85, which is 138% above median its own 10-year median of 5.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elekta AB stock overvalued right now?
Based on GuruFocus' analysis, Elekta AB (EKTAF) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.95, compared to a current price of $5.04 — trading 27.5% below its estimated fair value. The current OCF Yield % is 13.85, which is 138% above median its 10-year median of 5.83 and 709.9% above the Medical Devices & Instruments industry median of 1.71. Elekta AB's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Elekta AB (EKTAF), the current OCF Yield % is 13.85 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elekta AB (EKTAF) Overvalued in 2026?

Based on GuruFocus' analysis, Elekta AB stock appears to be undervalued. The current stock price of $5.04 is trading 27.5% below its estimated GF Value™ of $6.95. GuruFocus considers Elekta AB to be Modestly Undervalued.

Key valuation signals for EKTAF:

  • OCF Yield %: 13.85 (138% above median its 10-year median of 5.83)
  • GF Value™: $6.95 vs. price of $5.04 (27.5% below fair value)
  • GF Score™: 77/100 with 6 warning signs
  • Industry Position: 709.9% above the Medical Devices & Instruments median (#73 of 855)

No single metric tells the full story. See the EKTAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Elekta AB Business Description

Address Hagaplan 4, Box 7593, Stockholm, SWE, 11368
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 29%; Europe, the Middle East, and Africa accounting for 37%; and the Asia-Pacific contributing the remainder.
77GF Score

Get the complete analysis for EKTAF

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.04
Price
$6.95
GF Value